The government watchdog analyzed about 153 million radiology claims from a five-year period for its new report to Congress, with lawmakers now advocating for change.
Oulu University Hospital lost one of its MRI after relocation and consolidation but was able to maintain output with the help of deep-learning technology.
The money was meant for Minnesota, where criminals were indicted for abusing the Medicaid system to run bogus daycare centers. The Centers for Medicare & Medicaid Services did not specify how the state can rectify the situation to the Trump administration’s satisfaction.
The recall has been designed as the most serious Class I, but the issue can be remedied with a software update. The affected devices are Ivenix Large Volume Pumps, manufactured by Fresenius Kabi.
New research is sounding the alarm on the amount of radiation patients undergoing cardiac imaging are exposed to, prompting experts to call for updated protocols.
Cardiovascular disease is already the No. 1 killer among women—and new projections from the American Heart Association suggest things are going to get much worse. There are certain things that clinicians and patients can do, however, to help reverse this trend and save countless lives.
“These findings underscore the urgency for sustainable practices within neurointerventional care to reduce both environmental footprints and costs,” experts write in Radiology.
In the new role, Michael DeLeo, MD, MBA, will shape the company's physician management infrastructure, providing radiology services while leading strategic and operational initiatives.
Sycamore Partners took over the struggling retail pharmacy chain roughly six months ago, and the Private Equity Stakeholder Project fears early staffing cuts and store closures could spell trouble for the long-term health of the newly restructured business.
The government watchdog analyzed about 153 million radiology claims from a five-year period for its new report to Congress, with lawmakers now advocating for change.
![A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]](/sites/default/files/styles/stack_views/public/2024-09/istock-1209664264.jpg.webp?itok=MzQCOefT)
